Fbxw7β resides in the endoplasmic reticulum membrane and protects cells from oxidative stress

Cancer Science

Volumn 102, Issue 4, 2011, Pages 749-755

  Matsumoto, Akinobu ^a,b   Tateishi, Yuki ^a,b   Onoyama, Ichiro ^a,b   Okita, Yasutaka ^a,b   Nakayama, Keiko ^b,c   Nakayama, Keiichi I ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

F BOX PROTEIN; FBXW7ALPHA PROTEIN; FBXW7BETA PROTEIN; FBXW7GAMMA PROTEIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL PROTECTION; COMPLEX FORMATION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; FEMALE; GENE INSERTION; GENE OVEREXPRESSION; MALE; MOUSE; NERVE CELL CULTURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; ENDOPLASMIC RETICULUM; F-BOX PROTEINS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; INTEGRASES; INTRACELLULAR MEMBRANES; MALE; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; NEURONS; OXIDATIVE STRESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; UBIQUITIN-PROTEIN LIGASES;

EID: 79952766066     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.01851.x     Document Type: Article

References (55)

1. Nakayama KI, Nakayama K. Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer 2006; 6: 369-81.
2. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998; 67: 425-79.
3. Welcker M, Clurman BE. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 2008; 8: 83-93.
4. Yada M, Hatakeyama S, Kamura T et al. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J 2004; 23: 2116-25.
5. Hubbard EJ, Wu G, Kitajewski J, Greenwald I. sel-10, a negative regulator of lin-12 activity in Caenorhabditis elegans, encodes a member of the CDC4 family of proteins. Genes Dev 1997; 11: 3182-93.
6. Tetzlaff MT, Yu W, Li M et al. Defective cardiovascular development and elevated cyclin E and Notch proteins in mice lacking the Fbw7F-box protein. Proc Natl Acad Sci USA 2004; 101: 3338-45.
7. Tsunematsu R, Nakayama K, Oike Y et al. Mouse Fbw7/Sel-10/Cdc4 is required for notch degradation during vascular development. J Biol Chem 2004; 279: 9417-23.
8. Kwak EL, Moberg KH, Wahrer DCR et al. Infrequent mutations of Archipelago (hAGO, hCDC4, Fbw7) in primary ovarian cancer. Gynecol Oncol 2005; 98: 124-8.
9. Strohmaier H, Spruck CH, Kaiser P, Won KA, Sangfelt O, Reed SI. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 2001; 413: 316-22.
10. Byrd KN, Huey B, Roydasgupta R, Fridlyand J, Snijders AM, Albertson DG. FBXW7 and DNA copy number instability. Breast Cancer Res Treat 2008; 109: 47-54.
11. Yu JC, Ding SL, Chang CH et al. Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes. Carcinogenesis 2009; 30: 1562-70.
12. Zhao D, Zheng HQ, Zhou ZM, Chen CS. The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation. Cancer Res 2010; 70: 4728-38.
13. Cassia R, Moreno-Bueno G, Rodriguez-Perales S, Hardisson D, Cigudosa JC, Palacios J. Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma. J Pathol 2003; 201: 589-95.
14. Spruck CH, Strohmaier H, Sangfelt O et al. hCDC4 gene mutations in endometrial cancer. Cancer Res 2002; 62: 4535-9.
15. Milne AN, Leguit R, Corver WE et al. Loss of CDC4/FBXW7 in gastric carinoma. Cell Oncol 2010; 32: 347-59.
16. Yokobori T, Mimori K, Iwatsuki M et al. p53-altered FBXW7 expression determines poor prognosis in gastric cancer cases. Cancer Res 2009; 69: 3788-94.
17. Rajagopalan H, Jallepalli PV, Rago C et al. Inactivation of hCDC4 can cause chromosomal instability. Nature 2004; 428: 77-81.
18. Barber TD, McManus K, Yuen KWY et al. Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers. Proc Natl Acad Sci USA 2008; 105: 3443-8.
19. Iwatsuki M, Mimori K, Ishii H et al. Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance. Int J Cancer 2010; 126: 1828-37.
20. Asnafi V, Buzyn A, Le Noir S et al. NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for research on adult acute lymphoblastic leukemia (GRAALL) study. Blood 2009; 113: 3918-24.
21. Baldus CD, Thibaut J, Goekbuget N et al. Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia. Haematologica 2009; 94: 1383-90.
22. Clappier E, Collette S, Grardel N et al. NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951. Leukemia 2010; 24: 2023-31.
23. Erbilgin Y, Sayitoglu M, Hatirnaz O et al. Prognostic significance of NOTCH1 and FBXW7 mutations in pediatric T-ALL. Dis Markers 2010; 28: 353-60.
24. Gedman AL, Chen Q, Desmoulin SK et al. The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group. Leukemia 2009; 23: 1417-25.
25. Mansour MR, Sulis ML, Duke V et al. Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 Protocol. J Clin Oncol 2009; 27: 4352-6.
26. O'Neil J, Grim J, Strack P et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors. J Exp Med 2007; 204: 1813-24.
27. Park MJ, Taki T, Oda M et al. FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma. Br J Haematol 2009; 145: 198-206.
28. Song JH, Schnittke N, Zaat A, Walsh CS, Miller CW. FBXW7 mutation in adult T-cell and B-cell acute lymphocytic leukemias. Leuk Res 2008; 32: 1751-5.
29. Zuurbier L, Homminga I, Calvert V et al. NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols. Leukemia 2010; 24: 2014-22.
30. Mao JH, Perez-Losada J, Wu D et al. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene. Nature 2004; 432: 775-9.
31. Knuutila S, Aalto Y, Autio K et al. DNA copy number losses in human neoplasms. Am J Pathol 1999; 155: 683-94.
32. Fbw7 ubiquitin ligase. Science 2001; 294: 173-7.
33. Moberg KH, Bell DW, Wahrer DC, Haber DA, Hariharan IK. Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines. Nature 2001; 413: 311-6.
34. Spruck CH, Strohmaier HM. Seek and destroy: SCF ubiquitin ligases in mammalian cell cycle control. Cell Cycle 2002; 1: 250-4.
35. Welcker M, Orian A, Grim JE, Eisenman RN, Clurman BE. A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size. Curr Biol 2004; 14: 1852-7.
36. Fbw7 ubiquitin ligase. J Biol Chem 2004; 279: 50110-9.
37. Kimura T, Gotoh M, Nakamura Y, Arakawa H. hCDC4b, a regulator of cyclin E, as a direct transcriptional target of p53. Cancer Sci 2003; 94: 431-6.
38. Matsumoto A, Onoyama I, Nakayama KI. Expression of mouse Fbxw7 isoforms is regulated in a cell cycle- or p53-dependent manner. Biochem Biophys Res Commun 2006; 350: 114-9.
39. Onoyama I, Tsunematsu R, Matsumoto A et al. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis. J Exp Med 2007; 204: 2875-88.
40. Tronche F, Kellendonk C, Kretz O et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 1999; 23: 99-103.
41. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996; 85: 707-20.
42. Kip1, polyploidy and centrosome overduplication. EMBO J 2000; 19: 2069-81.
43. Hosokawa N, Kamiya Y, Kato K. The role of MRH domain-containing lectins in ERAD. Glycobiology 2010; 20: 651-60.
44. Matsuoka S, Oike Y, Onoyama I et al. Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL. Genes Dev 2008; 22: 986-91.
45. Onoyama I, Nakayama KI. Fbxw7 in cell cycle exit and stem cell maintenance: insight from gene-targeted mice. Cell Cycle 2008; 7: 3307-13.
46. Sancho R, Jandke A, Davis H, Diefenbacher ME, Tomlinson I, Behrens A. F-box and WD repeat domain-containing 7 regulates intestinal cell lineage commitment and is a haploinsufficient tumor suppressor. Gastroenterology 2010; 139: 929-41.
47. Fujii Y, Yada M, Nishiyama M et al. Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation. Cancer Sci 2006; 97: 729-36.
48. Wang Z, Li Y, Banerjee S, Sarkar FH. Exploitation of the Notch signaling pathway as a novel target for cancer therapy. Anticancer Res 2008; 28: 3621-30.
49. Weng AP, Aster JC. Multiple niches for Notch in cancer: context is everything. Curr Opin Genet Dev 2004; 14: 48-54.
50. Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 2003; 3: 859-68.
51. Shaulian E. AP-1-The Jun proteins: oncogenes or tumor suppressors in disguise? Cell Signal 2010; 22: 894-9.
52. Cdc4γ are required for cyclin E turnover in cell lines that do not overexpress cyclin E. Cell Cycle 2008; 7: 1075-82.
53. Wang H, Zhang X, Geng L, Teng L, Legerski RJ. Artemis regulates cell cycle recovery from the S phase checkpoint by promoting degradation of cyclin E. J Biol Chem 2009; 284: 18236-43.
54. Xu Y, Sengupta T, Kukreja L, Minella AC. MicroRNA-223 regulates cyclin E activity by modulating expression of F-box and WD-40 domain protein 7. J Biol Chem 2010; 285: 34439-46.
55. Grim JE, Gustafson MP, Hirata RK et al. Isoform- and cell cycle-dependent substrate degradation by the Fbw7 ubiquitin ligase. J Cell Biol 2008; 181: 913-20.